ID   PRGC2_RAT               Reviewed;        1010 AA.
AC   Q811R2;
DT   13-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2006, sequence version 2.
DT   02-OCT-2024, entry version 143.
DE   RecName: Full=Peroxisome proliferator-activated receptor gamma coactivator 1-beta;
DE            Short=PGC-1-beta;
DE            Short=PPAR-gamma coactivator 1-beta;
DE            Short=PPARGC-1-beta;
GN   Name=Ppargc1b; Synonyms=Perc, Pgc1, Pgc1b, Ppargc1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=12678921; DOI=10.1042/bj20030200;
RA   Meirhaeghe A., Crowley V., Lenaghan C., Lelliott C., Green K., Stewart A.,
RA   Hart K., Schinner S., Sethi J.K., Yeo G., Brand M.D., Cortright R.N.,
RA   O'Rahilly S., Montague C., Vidal-Puig A.J.;
RT   "Characterization of the human, mouse and rat PGC1 beta (peroxisome-
RT   proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro
RT   and in vivo.";
RL   Biochem. J. 373:155-165(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE SPLICING
RP   (ISOFORM 1).
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   FUNCTION.
RX   PubMed=12807885; DOI=10.1074/jbc.m303643200;
RA   Lin J., Tarr P.T., Yang R., Rhee J., Puigserver P., Newgard C.B.,
RA   Spiegelman B.M.;
RT   "PGC-1beta in the regulation of hepatic glucose and energy metabolism.";
RL   J. Biol. Chem. 278:30843-30848(2003).
CC   -!- FUNCTION: Plays a role of stimulator of transcription factors and
CC       nuclear receptors activities. Activates transcriptional activity of
CC       estrogen receptor alpha, nuclear respiratory factor 1 (NRF1) and
CC       glucocorticoid receptor in the presence of glucocorticoids. May play a
CC       role in constitutive non-adrenergic-mediated mitochondrial biogenesis
CC       as suggested by increased basal oxygen consumption and mitochondrial
CC       number when overexpressed. May be part of the pathways regulating the
CC       elevation of gluconeogenesis, beta-oxidation of fatty acids and
CC       ketogenesis during fasting. Stimulates SREBP-mediated lipogenic gene
CC       expression in the liver. Induces energy expenditure and antagonizes
CC       obesity when overexpressed. Induces also the expression of
CC       mitochondrial genes involved in oxidative metabolism. Induces the
CC       expression of PERM1 in the skeletal muscle in an ESRRA-dependent
CC       manner. {ECO:0000269|PubMed:12678921, ECO:0000269|PubMed:12807885}.
CC   -!- SUBUNIT: Interacts with estrogen receptor alpha/ESR1. Interacts with
CC       Sterol regulatory binding transcription factor 1/SREBF1, PPAR-
CC       alpha/PPARA, thyroid hormone receptor beta/THRB and host cell
CC       factor/HCFC1. Interacts with Estrogen-related receptor gamma/ESRRG and
CC       alpha/ESRRA. Interacts with PRDM16 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PGC1beta-1a;
CC         IsoId=Q811R2-1; Sequence=Displayed;
CC       Name=2; Synonyms=PGC1beta-2a;
CC         IsoId=Q811R2-2; Sequence=VSP_019303;
CC   -!- TISSUE SPECIFICITY: Ubiquitous with higher expression in heart, brown
CC       adipose tissue. {ECO:0000269|PubMed:12678921}.
CC   -!- INDUCTION: Induced by combination of forskolin and dexamethasone in
CC       primary hepatocytes.
CC   -!- DOMAIN: Contains 3 Leu-Xaa-Xaa-Leu-Leu (LXXLL) motif, which are usually
CC       required for the association with nuclear receptors. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY188951; AAO40026.1; -; mRNA.
DR   EMBL; AABR03110123; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03000001; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_788264.1; NM_176075.2. [Q811R2-1]
DR   AlphaFoldDB; Q811R2; -.
DR   SMR; Q811R2; -.
DR   STRING; 10116.ENSRNOP00000023661; -.
DR   PhosphoSitePlus; Q811R2; -.
DR   PaxDb; 10116-ENSRNOP00000023661; -.
DR   Ensembl; ENSRNOT00000023661.6; ENSRNOP00000023661.3; ENSRNOG00000017503.8. [Q811R2-1]
DR   Ensembl; ENSRNOT00055023820; ENSRNOP00055019420; ENSRNOG00055013837. [Q811R2-1]
DR   Ensembl; ENSRNOT00060043223; ENSRNOP00060035782; ENSRNOG00060024864. [Q811R2-1]
DR   Ensembl; ENSRNOT00065036526; ENSRNOP00065029432; ENSRNOG00065021452. [Q811R2-1]
DR   GeneID; 291567; -.
DR   KEGG; rno:291567; -.
DR   UCSC; RGD:727948; rat. [Q811R2-1]
DR   AGR; RGD:727948; -.
DR   CTD; 133522; -.
DR   RGD; 727948; Ppargc1b.
DR   eggNOG; ENOG502QTA7; Eukaryota.
DR   GeneTree; ENSGT00950000183137; -.
DR   HOGENOM; CLU_014202_0_0_1; -.
DR   InParanoid; Q811R2; -.
DR   OrthoDB; 3134278at2759; -.
DR   PhylomeDB; Q811R2; -.
DR   TreeFam; TF343068; -.
DR   PRO; PR:Q811R2; -.
DR   Proteomes; UP000002494; Chromosome 18.
DR   Bgee; ENSRNOG00000017503; Expressed in testis and 18 other cell types or tissues.
DR   GO; GO:0016592; C:mediator complex; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; IEA:GOC.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0050682; F:AF-2 domain binding; ISS:UniProtKB.
DR   GO; GO:0030331; F:nuclear estrogen receptor binding; ISO:RGD.
DR   GO; GO:0030374; F:nuclear receptor coactivator activity; ISS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003712; F:transcription coregulator activity; ISO:RGD.
DR   GO; GO:0007015; P:actin filament organization; ISO:RGD.
DR   GO; GO:0060346; P:bone trabecula formation; ISO:RGD.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; ISO:RGD.
DR   GO; GO:0030520; P:estrogen receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006390; P:mitochondrial transcription; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0001503; P:ossification; ISO:RGD.
DR   GO; GO:0045780; P:positive regulation of bone resorption; ISO:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0045672; P:positive regulation of osteoclast differentiation; ISO:RGD.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0051591; P:response to cAMP; IEP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   CDD; cd12356; RRM_PPARGC1B; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR034605; PGC-1.
DR   InterPro; IPR034177; PPARGC1B_RRM.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR15528; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1 PGC-1 -RELATED; 1.
DR   PANTHER; PTHR15528:SF12; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-BETA; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   SMART; SM00360; RRM; 1.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 1.
DR   PROSITE; PS50102; RRM; 1.
PE   2: Evidence at transcript level;
KW   Activator; Alternative splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; RNA-binding; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..1010
FT                   /note="Peroxisome proliferator-activated receptor gamma
FT                   coactivator 1-beta"
FT                   /id="PRO_0000240160"
FT   DOMAIN          889..963
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          1..91
FT                   /note="Abolishes DNA transcriptional activity when missing"
FT                   /evidence="ECO:0000250"
FT   REGION          115..134
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          165..214
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          227..282
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          306..329
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          369..475
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          517..567
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          590..674
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          714..744
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          778..881
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           140..144
FT                   /note="LXXLL motif 1"
FT   MOTIF           156..160
FT                   /note="LXXLL motif 2"
FT   MOTIF           342..346
FT                   /note="LXXLL motif 3"
FT   MOTIF           681..684
FT                   /note="HCFC1-binding-motif (HBM)"
FT   COMPBIAS        165..193
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        263..279
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        309..325
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        410..428
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        429..446
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        518..538
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        616..638
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        656..674
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        724..744
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        778..792
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        793..813
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        825..857
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         145
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VHJ7"
FT   MOD_RES         148
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VHJ7"
FT   MOD_RES         383
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YN6"
FT   MOD_RES         628
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YN6"
FT   VAR_SEQ         1..26
FT                   /note="MAGNDCGALLDEELSSFFLNYLSDTQ -> MQGEGK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12678921"
FT                   /id="VSP_019303"
SQ   SEQUENCE   1010 AA;  111589 MW;  E03266060CCA08CC CRC64;
     MAGNDCGALL DEELSSFFLN YLSDTQGGES GEEQLCADLP ELDLSQLDAS DFDSATCFGE
     LQWCPETSET EPSQYSPDDS EFFQIDSENE ALLAALTKTL DDIPEDDVGL AAFPGLDEGD
     TPSCTPASPA PLSVPPSPAL ERLLSPVSEV DELSLLQKLL LATSSPTASS DALKDGATWS
     QTSLSSRSQR PCVKVDGTQD KKTPMLRSQS RPCTELHKHL TSVLPCPRGK ACSPPPHPSP
     QLLSKEDEEV GEDCPSPWPA PASPQDSLGQ DTANPNSAQV PKDDVRAMVQ LIRYMHTYCL
     PQRKLPQRAS EPIPQSCSSP LRKVPPRSRQ TPKAFWTEFS ILRELLAQDI LCDVSKPYRL
     ATPVYASLTP QSRTRPPKDS QASPAHSAMA EEVRITASPK STGPRPSLRP LRLEVKRDVN
     KPARQKREED EEEEEEEEEE EEKEDEEEEW GRKRPGRGLP WTKLGRKMDS SVCPVRRSRR
     LNPELGPWLT FTDEPLGALP SMCLATETHD LEEELGGLTD SSQGQQLPLG SQIPTLESPC
     ESGCGDTDED PSCPRPPSRD SPRCLMLALS QSDPLGKKSF EESLTVELCG TAGLTPPTTP
     PYKPMEEDPF KQDTKHSPGQ DTAPSLPSPE TLQLTATPGA SHKLPKRHPE RSELLSHLQH
     ATTQPVSQAG QKRPFSCSFG DHDYCQVIRP EAALQRKVLR SWEPIKVHLE DLAHQGATLP
     VETKTPRREA DQNCDPTPKD SMQLRDHEIR ASLTKHFGLL ETALEEEDLA SCKSPEYDTV
     FEDSSSSSGE SSFLLEEEEE EGGEEDDEGE DSGVSPPCSD HCPYQSPPSK ASRQLCSRSR
     SSSGSSSCSS WSPATRKNFR LESRGPCSDG TPSARHAKKR REKAIGEGRV VYIRNLSGDM
     SSRELKKRFE VFGEIVECQV LRRSKRGQKH GFITFRCSEH AALSVRNGAT LRKRNEPSFH
     LSYGGLRHFR WPRYTDYDPT SEESLPSSGK SKYEAMDFDS LLKEAQQSLH
//
